Dr. Michel Sadelain, a pioneer of CAR T-cell therapy, is leading Columbia’s new initiative to expand the use of genetically engineered “living drugs” beyond cancer and into fields like autoimmunity and organ transplantation.
Groundbreaking research at Columbia is bringing the field of transplantation closer to eliminating lifelong immunosuppression, transforming the future for patients.
In a series of videos, leaders in lung, liver, heart, and kidney discuss a new Columbia initiative that brings every transplant division together through collaboration, research, and support.
Dr. Jason Hawksworth is one of the few surgeons in the U.S. doing complex liver surgery entirely on the robot. In this interview, he shares his passion for robotic surgery and plans for the future.
What started as a medical mission to save the life of one child in Venezuela has grown into a program that is building liver transplant programs for children across the Caribbean and Central America.
Empathy and solidarity lead to asking better questions, having deeper relationships with patients, and can advance life-saving research. We take a look at Non-Alcoholic Fatty Liver Disease with Dr. Julia Wattacheril.
